Analyst
Longwoodi Partners
Equibles does not estimate personal net worth.
Rupesh Tantia is recorded as Analyst at Longwoodi Partners. Rupesh Tantia has spoken on 1 earnings call across 1 company, most recently for Strides Pharma Science Limited on July 31, 2026. The companies whose calls Rupesh Tantia spoke on are classified in the Healthcare sector.
“First question, Ravi, is how many product launches are we looking to do this year? Because it seems like product launches have slowed down quite materially. So that is the first question.”
Longwoodi Partners
Analyst
Transcript header (unverified)
Strides Pharma Science Limited
Drug Manufacturers - Specialty & Generic · Healthcare
“Strides Pharma Science Limited Q1 FY27 Earnings Conference Call”
Strides Pharma Science Limited
